Holen Sie sich die Stockscreener-App
6.31
9.17%
0.53
Finanzdaten der 4 D Molecular Therapeutics Inc-Aktie (FDMT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
247.37%
0.028
|
-0.019 | 20.20 | 0.239 | 0.298 |
| Operating Expenses |
4.18%
38.16
|
36.63 | 34.18 | 32.38 | 30.40 |
| Benefits Costs and Expenses |
0.51%
32.43
|
32.26 | - | - | 28.98 |
| Costs And Expenses |
0.51%
32.43
|
32.26 | 34.18 | 32.38 | 28.98 |
| Depreciation and Amortization |
6.44%
1.173
|
1.102 | 0.994 | 1.079 | 1.029 |
| Operating Income/Loss |
4.05%
-38.14
|
-36.65 | -13.97 | -32.14 | -30.11 |
| Nonoperating Income/Loss |
31.27%
5.735
|
4.369 | 3.718 | 2.52 | 1.424 |
| Income/Loss From Continuing Operations Before Tax |
0.37%
-32.40
|
-32.28 | 20.20 | -29.62 | -28.68 |
| Income/Loss From Continuing Operations After Tax |
0.37%
-32.40
|
-32.28 | -10.26 | -29.62 | -28.68 |
Net Income/Loss
|
0.37%
-32.40
|
-32.28 | -10.26 | -29.62 | -28.68 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
3,855%
49.27
|
1.2457 | 42.26 | 38.34 | 32.72 |
| Diluted Average Shares |
3,855%
49.27
|
1.2457 | 42.26 | 38.34 | 32.72 |
| Basic Earnings Per Share |
14.29%
-0.66
|
-0.77 | -0.24 | -0.77 | -0.88 |
| Diluted Earnings Per Share |
14.29%
-0.66
|
-0.77 | -0.24 | -0.77 | -0.88 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):